Testing effectiveness (Phase 2)Study completedNCT02611258
What this trial is testing
Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs
Who this might be right for
Cushing's Syndrome Cardiomyopathy
Andrea M. Isidori 18